Articles

Misaligned incentives account for many of the most troubling features of the pharmaceutical industry’s present practices and performance.

Sara Wynn-Williams, defying Facebook’s attempts to silence her, reveals the company’s toxic culture and global damage, exposing unethical practices and a profit-at-any-cost approach. The key question she leaves us with: How can this be changed?

To understand politics in America, follow the money. When we do, we find good cause to expect McConnell’s shadow to live long beyond his tenure.

Fifty years ago the actions of the Federal Reserve mattered. Today, so far as the aggregate measures of the American domestic economy go, they do not.

Sociologist Michael A. McCarthy’s latest book shows how ordinary people can take back control of financial capitalism and make it work for them.

Ever since 2016, INET researchers confirmed the significance of economic issues in Trump’s ascendency.

Many voters, feeling disillusioned, are searching in vain for narratives that resonate with their experiences.

From the perspective of innovative enterprise, we ask how Musk might abuse his power of strategic control—and what that would mean for corporate governance reform.

A new book, The Hamilton Scheme, explores a very different founder than the one we’ve come to think we know.

Journalist Peter Goodman delves into the persistent problems with supply chains and how to fix them his new book, “How the World Ran Out of Everything,” in conversation with the Institute for New Economic Thinking